Citius Pharmaceuticals Inc (CTXR) stock news · $13.4M cap
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
This CTXR news page leads with what Citius Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for CTXR yet. We will not pad this page with generic market recap.
Latest reported CTXR revenue for 2026-06-30 was $1.5M. Net income was -$11.9M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CTXR stock page; for the tape open the quote page.
CTXR stock news FAQ
What are CTXR's latest revenue and net income?
Latest cached Citius Pharmaceuticals Inc (CTXR) revenue for Jun 30, 2026 was $1.5M. Net income was -$11.9M. Statements: https://lician.com/financials/ctxr
How did CTXR revenue change from the prior cached period?
Cached Citius Pharmaceuticals Inc (CTXR) revenue was down 10.4% from $1.7M (Mar 31, 2026) to $1.5M (Jun 30, 2026). Statements: https://lician.com/financials/ctxr
What is CTXR's market cap?
Citius Pharmaceuticals Inc (CTXR) market cap is $13.4M on the latest cached fundamentals snapshot.
What kind of company is CTXR?
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Where is CTXR stock news listed?
Cached stock news for Citius Pharmaceuticals Inc (CTXR) is listed at https://lician.com/news/ctxr. Filings: https://lician.com/sec/ctxr
Not investment advice.